Free Trial
ASX:RNO

Rhinomed (RNO) Stock Price, News & Analysis

About Rhinomed Stock (ASX:RNO)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
452,773 shs
Average Volume
N/A
Market Capitalization
A$11.47 million
P/E Ratio
N/A
Dividend Yield
3.01%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RNO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rhinomed and its competitors with MarketBeat's FREE daily newsletter.

RNO Stock News Headlines

Insider Buyers Lose AU$435k As Rhinomed Sheds AU$1.4m
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
Meredith George Bought 6.7% More Shares In Rhinomed \
See More Headlines

RNO Stock Analysis - Frequently Asked Questions

Rhinomed Limited (ASX:RNO) announced its quarterly earnings results on Thursday, February, 28th. The company reported ($0.02) earnings per share for the quarter. Rhinomed had a positive trailing twelve-month return on equity of 1,591.14% and a negative net margin of 145.98%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Rhinomed investors own include Pfizer (PFE), NVIDIA (NVDA), PayPal (PYPL), Advanced Micro Devices (AMD), Lowe's Companies (LOW), Energy Vault (NRGV) and Medicine Man Technologies (SHWZ).

Company Calendar

Last Earnings
2/28/2019
Today
7/04/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
ASX:RNO
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$10.91 million
Net Margins
-145.98%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$8.05 million
Price / Cash Flow
3.48
Book Value
A($0.02) per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
A$11.47 million
Optionable
Not Optionable
Beta
0.88
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (ASX:RNO) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners